pd 98059 and sphingosine phosphorylcholine

pd 98059 has been researched along with sphingosine phosphorylcholine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurabayashi, M; Nagai, R; Okajima, F; Sekiguchi, K; Yokoyama, T1
Ahn, DS; Cho, YE; Choi, SK; Kim, YH; Lee, YH; Morgan, KG; Ryu, SK1
Huh, CH; Kim, DS; Kwon, SB; Park, ES; Park, KC; Park, SH; Youn, SW1
Back, SJ; Kim, CD; Kwon, YB; Lee, JH; Lee, YS; Park, JK; Piao, YJ; Seo, YJ; Sohn, KC; Suhr, KB1
Jeong, HS; Kim, DS; Park, KC1
Byun, HJ; Kang, GJ; Kim, EJ; Kim, HJ; Lee, CH; Lee, H; Nam, S; Park, MK1

Other Studies

6 other study(ies) available for pd 98059 and sphingosine phosphorylcholine

ArticleYear
Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes.
    Circulation research, 1999, Nov-26, Volume: 85, Issue:11

    Topics: Adrenergic beta-Agonists; Animals; Animals, Newborn; Cell Size; Endothelin-1; Enzyme Inhibitors; Flavonoids; GTP-Binding Proteins; Heart; Hypertrophy; Isoproterenol; MAP Kinase Signaling System; Muscle Proteins; Myocardium; Pertussis Toxin; Phosphorylation; Phosphorylcholine; Protein Processing, Post-Translational; Rats; Sphingosine; Virulence Factors, Bordetella

1999
Augmented sphingosylphosphorylcholine-induced Ca2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat.
    Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 373, Issue:1

    Topics: Amides; Animals; Calcium; Flavonoids; Hypertension; Mesenteric Arteries; Mitogen-Activated Protein Kinases; Myosin Light Chains; Naphthalenes; Phosphorylation; Phosphorylcholine; Protein Kinase C; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; rho-Associated Kinases; Sphingosine; Vasoconstriction

2006
Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes.
    Pigment cell research, 2006, Volume: 19, Issue:2

    Topics: Antioxidants; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Male; MAP Kinase Signaling System; Melanins; Melanocytes; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Phosphorylcholine; Pigmentation; Pyrones; Ribosomal Protein S6 Kinases, 90-kDa; Sphingosine

2006
Sphingosylphosphorylcholine-induced interleukin-6 production is mediated by protein kinase C and p42/44 extracellular signal-regulated kinase in human dermal fibroblasts.
    Journal of dermatological science, 2007, Volume: 46, Issue:2

    Topics: Animals; Cells, Cultured; Dermis; Dose-Response Relationship, Drug; Enzyme Activation; Epidermis; Fibroblasts; Flavonoids; Humans; Indoles; Interleukin-6; Maleimides; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Phosphorylcholine; Protein Kinase C; Protein Kinase C-alpha; Protein Kinase Inhibitors; Rabbits; RNA, Messenger; Sphingosine; Tetradecanoylphorbol Acetate; Time Factors; Transfection; Wound Healing

2007
PP2A and DUSP6 are involved in sphingosylphosphorylcholine-induced hypopigmentation.
    Molecular and cellular biochemistry, 2012, Volume: 367, Issue:1-2

    Topics: Animals; Cell Line; Dual Specificity Phosphatase 6; Enzyme Activation; Enzyme Activators; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Hypopigmentation; MAP Kinase Signaling System; Melanins; Mice; Phosphorylation; Phosphorylcholine; Protein Phosphatase 2; Protein Processing, Post-Translational; Sphingosine

2012
Novel effects of sphingosylphosphorylcholine on invasion of breast cancer: Involvement of matrix metalloproteinase-3 secretion leading to WNT activation.
    Biochimica et biophysica acta, 2016, Volume: 1862, Issue:9

    Topics: Breast Neoplasms; Caproates; Cell Line, Tumor; Female; Flavonoids; Gene Silencing; Humans; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Phosphorylcholine; Polycyclic Compounds; Sphingosine; Valine; Wnt Signaling Pathway

2016